BridgeBio Pharma leading the pack after gaining 6.17%
Markets are mixed with Nasdaq up to 13,600, gaining 0.21%. Dow Jones slipping 0.14% and closing at 33,881.
Today's muted price action is occurring amid mixed market indicators – highly important Crude Oil Inventories data from United States beat analyst expectations of -1.76 million with a reading of -9.60 million.
Assets that recorded the greatest percentage change in relation to their peers are designated as "Top Movers" with the most active healthcare stocks listed below.
BridgeBio Pharma | +6.17% in mid-session
After hitting an important low of $6.74 approximately 5 months ago, the biotech developer has bounced back 141.69% since. So far this year, it has performed better than the Nasdaq by 103.82%. Currently, the clinical-stage biotechnology company has a market capitalization of $2.78 billion with an average daily volume of 1.92 million shares. BridgeBio Pharma's last revenue report was $1.83 million with an EPS of -92 cents.
Bearish run continues, Canopy Growth down to 43.81 cents (-7.57%)
Similar trend today: the Canadian cannabis supplier drops 7.57% in early trade and remains within touching distance of the 43.81 cents level. The cannabis producer's market cap currently stands at $257.00 million with an average daily trading volume of 12.39 million shares. So far this year, it has been doing worse than the Nasdaq by 102.86%.
Canopy Growth reported ambiguous earnings results Thursday, with revenue at $98.15 million, compared to a consensus of $73.19 million. Since the release of its earnings report, Canopy Growth lost 26.96%.
Bright Health currently down 5.43% halfway through today
More of the same today: the health insurance provider drops 5.43% in early trade and remains within touching distance of the $10.79 level. Currently, the health insurance provider has a market capitalization of $85.80 million with an average daily trading volume of 439,447 shares. So far this year, it has been beating the Nasdaq by 1,897.52%.